tenk.fyi

Pelthos Therapeutics Inc.

PTHSNYSE· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$8.0M

7.8% YoY

EPS

$-1.43

75.3% YoY

Cash

$513,443

432.7% YoY

FY 2024 · As of 2024-12-31